CO7190239A2 - Dialisato a base de polímero - Google Patents
Dialisato a base de polímeroInfo
- Publication number
- CO7190239A2 CO7190239A2 CO14250262A CO14250262A CO7190239A2 CO 7190239 A2 CO7190239 A2 CO 7190239A2 CO 14250262 A CO14250262 A CO 14250262A CO 14250262 A CO14250262 A CO 14250262A CO 7190239 A2 CO7190239 A2 CO 7190239A2
- Authority
- CO
- Colombia
- Prior art keywords
- polymer based
- dialysate
- based dialysate
- polyglycerol
- kda
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title 1
- 229920000223 polyglycerol Polymers 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 239000002357 osmotic agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
- C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0014—Special media to be introduced, removed or treated removed from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0496—Urine
- A61M2202/0498—Urea
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2340/00—Filter material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Polyethers (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Las incorporaciones descritas en el presente proporcionan un dialisato que comprende un poliglicerol. El poliglicerol puede tener un peso molecular entre alrededor de 0.15 kDa a alrededor de 60 kDa. También se proporciona en el presente el uso del dialisato como un agente de difusión y como un agente osmótico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261637716P | 2012-04-24 | 2012-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7190239A2 true CO7190239A2 (es) | 2015-02-19 |
Family
ID=49482059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO14250262A CO7190239A2 (es) | 2012-04-24 | 2014-11-12 | Dialisato a base de polímero |
Country Status (15)
Country | Link |
---|---|
US (1) | US9919004B2 (es) |
EP (1) | EP2841078A4 (es) |
JP (1) | JP6240665B2 (es) |
KR (1) | KR20150013161A (es) |
CN (1) | CN104640550A (es) |
AU (1) | AU2013252433B2 (es) |
BR (1) | BR112014026616A2 (es) |
CA (1) | CA2871277A1 (es) |
CL (1) | CL2014002891A1 (es) |
CO (1) | CO7190239A2 (es) |
HK (1) | HK1203388A1 (es) |
MX (1) | MX2014012942A (es) |
MY (1) | MY170307A (es) |
PE (1) | PE20150288A1 (es) |
WO (1) | WO2013159188A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006130978A1 (en) | 2005-06-06 | 2006-12-14 | The University Of British Columbia | Polymer-based serum albumin substitute |
CA2791416C (en) | 2010-03-01 | 2018-05-15 | The University Of British Columbia | Derivatized hyperbranched polyglycerols |
EP3071030B1 (en) * | 2013-11-21 | 2020-03-25 | Jayachandran Kizhakkedathu | Polymer based transplant preservation solution |
EP3148553A4 (en) | 2014-05-29 | 2017-11-29 | The University Of British Columbia | Antithrombotic compounds, methods and uses thereof |
EP3120842A1 (en) | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
JP6721880B2 (ja) * | 2016-03-25 | 2020-07-15 | 国立大学法人神戸大学 | 正浸透膜を使用して膜分離する方法 |
US10874790B2 (en) | 2016-08-10 | 2020-12-29 | Medtronic, Inc. | Peritoneal dialysis intracycle osmotic agent adjustment |
GR1009311B (el) * | 2017-01-26 | 2018-06-19 | Βερμα Ντραγκς - Verma Drugs Abee | Οξινο κιτρικο διαλυμα αιμοκαθαρσης με l-καρνιτινη |
EP3381484A1 (en) * | 2017-03-31 | 2018-10-03 | Opterion Health AG | Carbohydrate composition for dialysis |
WO2019210414A1 (en) * | 2018-05-02 | 2019-11-07 | Arc Medical Devices Inc. | Fucan-based compounds and complexes |
US11806457B2 (en) * | 2018-11-16 | 2023-11-07 | Mozarc Medical Us Llc | Peritoneal dialysis adequacy meaurements |
US11806456B2 (en) | 2018-12-10 | 2023-11-07 | Mozarc Medical Us Llc | Precision peritoneal dialysis therapy based on dialysis adequacy measurements |
US11965763B2 (en) | 2021-11-12 | 2024-04-23 | Mozarc Medical Us Llc | Determining fluid flow across rotary pump |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3461210A (en) | 1967-07-20 | 1969-08-12 | Unimed Inc | Reduction of intraocular pressure |
JPS61247466A (ja) | 1985-04-25 | 1986-11-04 | テルモ株式会社 | 腹膜透析用透析液 |
US20030202958A1 (en) * | 1999-10-15 | 2003-10-30 | Strickland Alan D. | Dialysis solution including polyglycol osmotic agent |
DE60024479T2 (de) * | 1999-10-15 | 2006-05-18 | Dow Global Technologies, Inc., Midland | Dialyselösung die polyglycol als osmotischen mittels enthält |
US6949335B2 (en) | 1999-11-30 | 2005-09-27 | 21St Century Medicine, Inc. | Polyglycerol and lactose compositions for the protection of living systems from states of reduced metabolism |
WO2006130978A1 (en) | 2005-06-06 | 2006-12-14 | The University Of British Columbia | Polymer-based serum albumin substitute |
DE102006036326A1 (de) * | 2006-08-03 | 2008-02-07 | Charité - Universitätsmedizin Berlin | Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen |
WO2008074154A1 (en) | 2006-12-18 | 2008-06-26 | The University Of British Columbia | Polymers comprising zwitterionic endgroups |
WO2009055935A1 (en) | 2007-11-02 | 2009-05-07 | The University Of British Columbia | Hyperbranched polyglycerol for improving heart function |
CA2791416C (en) | 2010-03-01 | 2018-05-15 | The University Of British Columbia | Derivatized hyperbranched polyglycerols |
US8519189B2 (en) | 2011-06-01 | 2013-08-27 | University Of British Columbia | Polymers for reversing heparin-based anticoagulation |
-
2013
- 2013-04-18 CN CN201380032067.7A patent/CN104640550A/zh active Pending
- 2013-04-18 EP EP13780839.0A patent/EP2841078A4/en not_active Withdrawn
- 2013-04-18 MX MX2014012942A patent/MX2014012942A/es unknown
- 2013-04-18 AU AU2013252433A patent/AU2013252433B2/en not_active Ceased
- 2013-04-18 CA CA2871277A patent/CA2871277A1/en not_active Abandoned
- 2013-04-18 MY MYPI2014003013A patent/MY170307A/en unknown
- 2013-04-18 BR BR112014026616A patent/BR112014026616A2/pt not_active IP Right Cessation
- 2013-04-18 KR KR1020147031465A patent/KR20150013161A/ko not_active Application Discontinuation
- 2013-04-18 WO PCT/CA2013/000382 patent/WO2013159188A1/en active Application Filing
- 2013-04-18 US US14/396,603 patent/US9919004B2/en not_active Expired - Fee Related
- 2013-04-18 JP JP2015507307A patent/JP6240665B2/ja not_active Expired - Fee Related
- 2013-04-18 PE PE2014001790A patent/PE20150288A1/es not_active Application Discontinuation
-
2014
- 2014-10-24 CL CL2014002891A patent/CL2014002891A1/es unknown
- 2014-11-12 CO CO14250262A patent/CO7190239A2/es unknown
-
2015
- 2015-04-24 HK HK15104009.4A patent/HK1203388A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PE20150288A1 (es) | 2015-02-22 |
AU2013252433A1 (en) | 2014-11-20 |
US20150141512A1 (en) | 2015-05-21 |
CN104640550A (zh) | 2015-05-20 |
HK1203388A1 (en) | 2015-10-30 |
EP2841078A1 (en) | 2015-03-04 |
JP2015515481A (ja) | 2015-05-28 |
JP6240665B2 (ja) | 2017-11-29 |
MX2014012942A (es) | 2015-02-10 |
EP2841078A4 (en) | 2015-11-04 |
BR112014026616A2 (pt) | 2017-06-27 |
KR20150013161A (ko) | 2015-02-04 |
US9919004B2 (en) | 2018-03-20 |
CL2014002891A1 (es) | 2015-05-04 |
AU2013252433B2 (en) | 2017-12-14 |
CA2871277A1 (en) | 2013-10-31 |
MY170307A (en) | 2019-07-17 |
WO2013159188A1 (en) | 2013-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO7190239A2 (es) | Dialisato a base de polímero | |
UY34566A (es) | 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
GT201500063A (es) | Nanopartículas terapéuticas que comprenden un agente terapéutico y métodos para realizarlas y usarlas | |
BR112015027321A2 (pt) | composições e métodos | |
CR20150277A (es) | Piridina-2-amidas utiles como agonistas cb2 | |
ECSP15026557A (es) | Compuestos y sus métodos de empleo | |
ECSP10010206A (es) | Inhibidores de la replicación del virus de la imunodeficiencia humana | |
UY34538A (es) | Heteroarilos y usos de los mismos | |
CR20150204A (es) | Nuevos derivados de piridina | |
UY34419A (es) | Profármaco de adrenomedulina basado en polietilenglicol y el uso del mismo | |
CR20150211A (es) | Compuestos diméricos | |
UY34610A (es) | Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos. | |
DOP2016000170A (es) | Compuestos derivados de hidroxiformamida y usos del mismo | |
UY34773A (es) | Ácidos indanoiloxidihidrobenzofuranilacéticos como moduladores de la actividad de gpr40, composiciones que los contienen y sus usos | |
PE20150226A1 (es) | Agentes terapeuticos para administracion subcutanea optimizados | |
EA201590503A1 (ru) | Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями | |
BR112017021190A2 (pt) | composição farmacêutica e o uso da mesma | |
CL2015001446A1 (es) | Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido. | |
DOP2016000021A (es) | Imidazotiazol sulfonamidas como nematicidas | |
UY34761A (es) | Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos. | |
CR20120166A (es) | Composiciones y productos antimicrobianos | |
AR095937A1 (es) | Potenciador de la solubilidad en agua a base de glucógeno | |
BR112015023730A2 (pt) | uso de sedoeptulose como suplemento nutricional | |
BR112014012325A2 (pt) | fibra de poliolefina | |
CR20150641U (es) | Composiciones farmacéuticas |